Julia Asp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Julia Asp has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anders Lindahl
University of Gothenburg
2 shared publications Anders Jeppsson
Department of Molecular and Clinical Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
1 shared publication- Göran Dellgren
Dept Cardiothoracic Surgery and Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden; Institution of Clinical Sciences, Dept of Surgery, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden
1 shared publication - Joakim Sandstedt
University of Gothenburg
1 shared publication Lara Molendini
Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli, Bologna, Italy
1 shared publicationLuca Sangiorgi
Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli, Bologna, Italy
1 shared publication
Latest Publications
- 1 January 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 443 (1) , 234-238
Human C-kit+CD45− cardiac stem cells are heterogeneous and display both cardiac and endothelial commitment by single-cell qPCR analysis
- 1 January 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 443 (1) , 234-238
Human C-kit+CD45− cardiac stem cells are heterogeneous and display both cardiac and endothelial commitment by single-cell qPCR analysis
- Open Access
- 8 March 2000
- Published by Wiley in International Journal of Cancer
- Vol. 85 (6) , 782-786
Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues
The role of two important tumour suppressor genes, p16 and p53, was evaluated in cartilaginous tumour tissues. Genomic DNA from 22 chondrosarcomas, 5 benign chondroid tumours, 1 sample of reactive proliferative cartilage and 2 samples of normal cartilage were analysed using polymerase chain reaction, single strand conformational polymorphism, DNA sequencing and methylation‐specific polymerase chain reaction. The p16 gene was found to be partly methylated in 5 high‐grade chondrosarcomas and homozygously deleted in 1 chondrosarcoma. Moreover, a polymorphism was detected in 3 malignant tumours, but not in benign tumours or normal cartilage. Analysis of the p53 gene revealed an unchanged structure in all samples. These findings show a role for p16, but not p53, in chondrosarcoma. Int. J. Cancer 85:782–786, 2000.
- 8 March 2000
- Published by Wiley in International Journal of Cancer
- Vol. 85 (6) , 782-786
Open AccessChanges of the p16 gene but not the p53 gene in human chondrosarcoma tissues
The role of two important tumour suppressor genes, p16 and p53, was evaluated in cartilaginous tumour tissues. Genomic DNA from 22 chondrosarcomas, 5 benign chondroid tumours, 1 sample of reactive proliferative cartilage and 2 samples of normal cartilage were analysed using polymerase chain reaction, single strand conformational polymorphism, DNA sequencing and methylation‐specific polymerase chain reaction. The p16 gene was found to be partly methylated in 5 high‐grade chondrosarcomas and homozygously deleted in 1 chondrosarcoma. Moreover, a polymorphism was detected in 3 malignant tumours, but not in benign tumours or normal cartilage. Analysis of the p53 gene revealed an unchanged structure in all samples. These findings show a role for p16, but not p53, in chondrosarcoma. Int. J. Cancer 85:782–786, 2000.